Table 1.
The clinical outcome and the B and T cell memory responses after exposure to influenza viruses are summarized below.
Influenza antigenic site change | ||||
---|---|---|---|---|
Antigenic drift Genetic changes in Ag sites alter Ab binding | Antigenic shift | |||
None | Minimal | Major | Exchange of surface Glycoproteins | |
Clinical outcome | Little to no symptoms | Unpredictable (135) | Dependent of CD8+ T cell response •Limited by HLA alleles (136, 197) •Prior exposure to influenza (137–139) T cell memory pool and quality of T cell response (137–139) ⇒ Severe to fatal outcome with prolonged hospitalizations (137) |
|
B cell response | Robust memory B cell response and protective Ab production (135) | Dominated by memory B cells against preserved antigenic sites, yielding a protective but focused Ab response that may not protect against future drift. | Cross-reactive memory B cells produce an early unadapted Ab response to limit virus replication and symptoms, and enter GC reactions to generate updated memory and PCs If enough Ag available, naïve B cells react and generate updated B cell memory | Very limited (if any) protection by memory B cells (31, 140)Response driven by naïve B cells |
CD8+ T cell response | Cross-reactive Not responsive if B cells neutralize the virus | Cross-reactive but not neutralizing immunityHost-specific differences |